이식용 HLA 타이핑 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품·서비스별, 기술별, 용도별, 이식 유형별, 지역별, 경쟁별 세분화(2020-2030년)

The Global HLA Typing for Transplant Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.91% to reach USD 2.87 Billion by 2030. Human Leukocyte Antigen (HLA) typing for transplant is a molecular diagnostic process identifying specific HLA genes and proteins to determine compatibility between organ and stem cell donors and recipients, thereby minimizing immune rejection and enhancing transplant success.

Key Market Drivers

The escalating global demand for organ and stem cell transplants significantly propels the Human Leukocyte Antigen typing market. The rising prevalence of chronic diseases like end-stage renal disease, liver failure, and various hematologic malignancies necessitates these life-saving procedures. This increasing demand directly translates into a greater need for precise HLA compatibility assessment to ensure successful engraftment and minimize rejection rates.

Key Market Challenges

The persistent global shortage of compatible donor organs significantly impedes the expansion of the Global Human Leukocyte Antigen typing for transplant market. The foundational demand for HLA typing is intrinsically linked to the volume of transplant procedures performed, as these diagnostic tests are essential for assessing donor-recipient compatibility and mitigating immune rejection. A scarcity of available organs directly limits the number of potential transplant surgeries, thereby reducing the overall requirement for HLA typing.

Key Market Trends

The increasing application of Artificial Intelligence in Human Leukocyte Antigen data analysis is enhancing the precision of donor-recipient matching for transplantation. AI algorithms efficiently process extensive genomic data, enabling sophisticated pattern recognition and predictive modeling essential for navigating the complex polymorphism of HLA genes. This capability directly improves transplant success rates by identifying optimal matches and mitigating immune complications.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• Immucor, Inc.
• Caredx. Inc.
• Luminex Corporation (Diasorin)
• Tbg Diagnostics Limited

Report Scope:

In this report, the Global HLA Typing for Transplant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

HLA Typing for Transplant Market, By Product & Service:

• Reagents & Consumables
• Instruments
• Software & Services

HLA Typing for Transplant Market, By Technology:

• Molecular Assay Technologies
• Non-molecular Assay Technologies

HLA Typing for Transplant Market, By Application:

• Diagnostic Applications
• Antibody Screening
• Chimerism Monitoring
• Research Applications
• Others

HLA Typing for Transplant Market, By Transplant Type:

• Solid Organ Transplant
• Soft Tissue Transplant

HLA Typing for Transplant Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global HLA Typing for Transplant Market.

Available Customizations:

Global HLA Typing for Transplant Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global HLA Typing for Transplant Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Reagents & Consumables, Instruments, Software & Services)
  • 5.2.2. By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies)
  • 5.2.3. By Application (Diagnostic Applications, Antibody Screening, Chimerism Monitoring, Research Applications, Others)
  • 5.2.4. By Transplant Type (Solid Organ Transplant, Soft Tissue Transplant)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America HLA Typing for Transplant Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Service
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Transplant Type
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States HLA Typing for Transplant Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Service
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Transplant Type
  • 6.3.2. Canada HLA Typing for Transplant Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Service
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Transplant Type
  • 6.3.3. Mexico HLA Typing for Transplant Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Service
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Transplant Type

7. Europe HLA Typing for Transplant Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Service
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Transplant Type
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany HLA Typing for Transplant Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Service
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Transplant Type
  • 7.3.2. France HLA Typing for Transplant Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Service
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Transplant Type
  • 7.3.3. United Kingdom HLA Typing for Transplant Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Service
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Transplant Type
  • 7.3.4. Italy HLA Typing for Transplant Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Service
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Transplant Type
  • 7.3.5. Spain HLA Typing for Transplant Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Service
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Transplant Type

8. Asia Pacific HLA Typing for Transplant Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Service
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Transplant Type
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China HLA Typing for Transplant Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Service
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Transplant Type
  • 8.3.2. India HLA Typing for Transplant Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Service
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Transplant Type
  • 8.3.3. Japan HLA Typing for Transplant Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Service
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Transplant Type
  • 8.3.4. South Korea HLA Typing for Transplant Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Service
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Transplant Type
  • 8.3.5. Australia HLA Typing for Transplant Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Service
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Transplant Type

9. Middle East & Africa HLA Typing for Transplant Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Service
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Transplant Type
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia HLA Typing for Transplant Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Service
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Transplant Type
  • 9.3.2. UAE HLA Typing for Transplant Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Service
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Transplant Type
  • 9.3.3. South Africa HLA Typing for Transplant Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Service
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Transplant Type

10. South America HLA Typing for Transplant Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Service
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Transplant Type
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil HLA Typing for Transplant Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Service
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Transplant Type
  • 10.3.2. Colombia HLA Typing for Transplant Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Service
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Transplant Type
  • 10.3.3. Argentina HLA Typing for Transplant Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Service
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Transplant Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global HLA Typing for Transplant Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Illumina, Inc.
• 15.3. Qiagen N.V.
• 15.4. Bio-Rad Laboratories, Inc.
• 15.5. F. Hoffmann-La Roche Ltd
• 15.6. Immucor, Inc.
• 15.7. Caredx. Inc.
• 15.8. Luminex Corporation (Diasorin)
• 15.9. Tbg Diagnostics Limited

16. Strategic Recommendations

17. About Us & Disclaimer